Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

6.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Creative thinking in Parkinson's disease: A systematic review and meta-analysis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Correction: Long-term neurological outcome after hematopoietic stem cell transplant in juvenile Krabbe disease.

Journal of neurology·2026
Same author

Pharmacological Interventions for Hereditary Transthyretin-Related Amyloidosis With Polyneuropathy: Systematic Review and Network Meta-Analysis.

European journal of neurology·2026
Same author

A Quantitative Assessment of Upper Limb Motor Function Across Disease Stages in Hereditary Transthyretin Amyloidosis.

Journal of the peripheral nervous system : JPNS·2026
Same author

ChatGPT in the diagnosis and management of complex polyneuropathies: comparative analysis with neurologists using real-world cases.

NPJ digital medicine·2026
Same author

Deep Phenotyping of F64L Mutation in a Multicentric Cohort of Patisiran-Treated Hereditary Transthyretin Amyloidosis Patients (Patisiranitaly).

European journal of neurology·2026

Related Experiment Video

Updated: Apr 26, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.1K

Brain fluorodeoxyglucose PET in adrenoleukodystrophy.

Ettore Salsano1, Giorgio Marotta2, Valentina Manfredi2

  • 1From the Departments of Clinical Neurosciences (E.S., D.P.), Diagnostics and Applied Technology (V.M., A.R.G., L.F., M.S.), and Child Neurology (G.U.), Fondazione IRCCS, Istituto Neurologico "C. Besta," Milano, Italy; and Department of Nuclear Medicine (G.M., R.B.), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy. ettore.salsano@istituto-besta.it.

Neurology
|August 8, 2014
PubMed
Summary

Brain [18F]-fluorodeoxyglucose PET (FDG-PET) reveals altered glucose metabolism in X-linked adrenoleukodystrophy (X-ALD) patients. These metabolic changes correlate with clinical severity and are detectable independently of MRI findings.

More Related Videos

Fluorescence-Activated Cell Sorting-Radioligand Treated Tissue FACS-RTT to Determine the Cellular Origin of Radioactive Signal
12:04

Fluorescence-Activated Cell Sorting-Radioligand Treated Tissue FACS-RTT to Determine the Cellular Origin of Radioactive Signal

Published on: September 10, 2021

1.8K
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.1K

Related Experiment Videos

Last Updated: Apr 26, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.1K
Fluorescence-Activated Cell Sorting-Radioligand Treated Tissue FACS-RTT to Determine the Cellular Origin of Radioactive Signal
12:04

Fluorescence-Activated Cell Sorting-Radioligand Treated Tissue FACS-RTT to Determine the Cellular Origin of Radioactive Signal

Published on: September 10, 2021

1.8K
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.1K

Area of Science:

  • Neuroimaging
  • Neurometabolism
  • Genetics

Background:

  • X-linked adrenoleukodystrophy (X-ALD) is a rare genetic disorder affecting the adrenal glands and white matter of the brain.
  • Cerebral glucose metabolism alterations are implicated in X-ALD pathogenesis, but their relationship with clinical presentation and MRI findings requires further investigation.

Purpose of the Study:

  • To investigate cerebral glucose metabolism in X-ALD patients using [18F]-fluorodeoxyglucose Positron Emission Tomography (FDG-PET).
  • To correlate metabolic findings with clinical severity, neuropsychological assessments, and personality profiles.

Main Methods:

  • A cross-sectional study involving 12 adult X-ALD patients and 27 healthy controls.
  • Clinical evaluation, brain MRI, FDG-PET, neuropsychological testing, and personality/psychopathology assessments (SCL-90-R, MCMI-III).

Main Results:

  • X-ALD patients exhibited increased frontal lobe glucose metabolism and reduced metabolism in cerebellar and temporal areas compared to controls.
  • Frontal lobe hypermetabolism significantly correlated with X-ALD clinical scores.
  • Obsessive-compulsive personality traits were common, correlating with glucose uptake in the ventral striatum.

Conclusions:

  • FDG-PET reveals X-ALD-related brain glucose metabolism abnormalities independent of MRI findings.
  • Cerebral metabolic alterations detected by FDG-PET correlate with clinical severity in X-ALD.
  • FDG-PET is a valuable tool for characterizing X-ALD and potentially other leukodystrophies.